[1]
Stenmark, F. et al. 2022. Treatment with CoreTherm in 570 patients with prostate volumes of 80-366 ml: an evaluation of short- and long-term retreatment risk. Scandinavian Journal of Urology. 56, 4 (Jul. 2022), 336–341. DOI:https://doi.org/10.1080/21681805.2022.2108139.